Home LiteratureArticle Details
PMID: 26962911 Published · ppublish English Letter Comment

Treatment of Advanced Renal-Cell Carcinoma.

The New England journal of medicine ·Vol. 374 ·No. 9 ·2016-00-03 ·Pages 889-90

Motzer RJ, Escudier B, Choueiri TK

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Carcinoma, Renal Cell/drug therapy Female Humans Kidney Neoplasms/drug therapy Male Sirolimus/analogs & derivatives
Chemicals
Antibodies, Monoclonal Antineoplastic Agents Sirolimus
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Motzer Robert J
Escudier Bernard
Choueiri Toni K
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMc1515613
Published
2016-00-03
Pages
889-90
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 26406148
CommentOn
PMID: 26962912
CommentOn
PMID: 26962913
External Links
PubMed source DOI: 10.1056/NEJMc1515613 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2